Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients

<p>Abstract</p> <p>Background</p> <p>About 130 million people are infected with the hepatitis C virus (HCV) worldwide, but effective treatment options are not yet available. One of the most promising targets for antiviral therapy is nonstructural protein 3 (NS3). To identify possible changes in the...

詳細記述

書誌詳細

主要な著者:	Palma Mário S, Nogueira Maurício L, Pinho João Renato R, de Carvalho-Mello Isabel Maria VG, Arcuri Helen A, Provazzi Paola JS, Rahal Paula
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2010-07-01
シリーズ:	BMC Research Notes
オンライン･アクセス:	http://www.biomedcentral.com/1756-0500/3/196
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!